| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 13 | |
| #2 | Canada | 1 | |
| #3 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wade John Desmond | 5 |
| #2 | Gundlach Andrew Lawrence | 5 |
| #3 | Bathgate Ross Alexander David | 5 |
| #4 | Hossain Mohammed Akhter | 3 |
| #5 | Tregear Geoffrey | 2 |
| #6 | Mendelsohn Frederick A O | 2 |
| #7 | Rosengren Karl Johan | 2 |
| #8 | Burazin Tanya Christine | 2 |
| #9 | Haugaard-Kedstrom Linda Maria | 2 |
| #10 | Lawrence Andrew J | 2 |
| Publication | Filing date | Title |
|---|---|---|
| AU2013202269A1 | Compositions and methods for the treatment of fibrosis and fibrotic diseases | |
| AU2008207287A1 | Use of galanin in a method of treating neurodegenerative diseases or conditions | |
| AU2006332449A1 | A method of treatment | |
| AU2006287124A1 | Prophylactic and therapeutic agents and uses therefor | |
| AU2005282229A1 | Enzyme inhibitors and uses thereof | |
| AU2004249329A1 | Relaxin superfamily peptide analogues | |
| ZA200402764B | Human 3 relaxin | |
| AU2002317634B2 | Modulation of insulin-regulated aminopeptidase (IRAP)/Angiotensin IV (AT4) receptor activity |